Merck KGaA to ask EU agency to reconsider MS oral drug

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Merck KGaA to ask EU agency to reconsider MS oral drug

Post by MSUK » Mon Oct 11, 2010 1:44 am

Image

German drugmaker Merck KGaA plans to ask a European watchdog to review a negative opinion issued on multiple sclerosis drug cladribine last month that said the drug's risks outweighed its benefits.

"Merck is committed to the potential of cladribine tablets to meet an unmet medical need as an oral, short-course, disease-modifying drug for multiple sclerosis," the group said in a statement on Monday.

The drug was dealt a major blow in September when the Committee for Medicinal Products for Human Use (CHMP), whose view is invariably adopted by the European Commission for approval of decisions, found that the drug may not be fit for approval. [ID:nLDE68N04J]... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1629
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post